Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Male or female ≥ 10 years of age
Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis of HS
Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.
None
HS Patients
Cohort
Prospective
Not listed
Primary Objective
The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa.
Secondary Objective
Secondary aims include correlating alterations in clinical and biological characteristics with disease status, and identifying genetic variants that predict disease progression or response to therapy.
Click on the lead sponsor to view all of their trials.
University of California, San Francisco
Lead sponsor
UCB Pharma
Collaborator
